2652 — CF PharmTech Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- HK$2.31bn
- HK$2.04bn
- CNY607.75m
Brief: CF Pharmtech To Place 21.7 MLN New H Shares At HK$13.82 Per Share
Brief: CF Pharmtech Says Nmpa Approves Ind Application For ICF004 As Class 1 New Drug
Brief: CF Pharmtech Inc To Nominate Zhang Jingjing As Candidate For Executive Director
CF PharmTech climbs most in 4 weeks on product marketing application in Asia
Brief: CF Pharmtech Announces Strategic Cooperation With JD Health
Brief: CF Pharmtech Expects 2025 Revenue Of Rmb410 Million-Rmb450 Million
CF PharmTech jumps most on record on new hypertension drug application
Brief: CF Pharmtech Announces Approval Of Clinical Trial Application For Olopatadine Hydrochloride, Mometasone Furoate Monohydrate Nasal Spray
Brief: CF Pharmtech Says NMPA Accepted IND Application For ICF004
Brief: CF Pharmtech Inc Says NMPA Accepts Marketing Authorization Application For Budesonide Nasal Spray
Brief: CF Pharmtech Says NMPA Accepts Clinical Trial Application For Olopatadine Hydrochloride And Mometasone Furoate Monohydrate Nasal Spray
China's CF PharmTech surges in Hong Kong debut